openPR Logo
Press release

Psychotic Disorder Treatment Market to Witness Widespread Expansion During 2017 to 2027

07-17-2018 01:58 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

/ PR Agency: Fact.MR
Psychotic Disorder Treatment Market to Witness Widespread

Psychotic disorders are mental disorders in which a person’s personality is affected severely due to brain damage. When a psychotic episode happens, a person becomes uncertain about reality and usually experiences delusions, hallucinations, off-the-wall behavior, incoherency and chaotic speech. Psychotic disorders generally shows two main symptoms that are hallucinations and delusions. Hallucinations are wrong perceptions, such as seeing, hearing or feeling something that is not present. Delusions are wrong beliefs, involving real-life conditions that could not be true, such as having a disease. Depending on the causes, psychotic disorder can come slowly or quickly. Psychosis is not a permanent state rather it can be cured. The exact cause of psychotic disorder is unclear but psychosis is usually results from brain abnormalities. Psychotic disorder can also be associated with dementia, stroke, schizophrenia, brain tumors, bipolar disorders, heavy use and adverse effect to alcohol or drugs. Medication plays an important role in the treatment of psychotic disorder. Highly-effective treatments are available to treat psychotic disorder which includes antipsychotic medication, cognitive behavioral therapy, supportive psychotherapy and case management.

Get Brochure of The Report: https://www.factmr.com/connectus/sample?flag=B&rep_id=568
Psychotic Disorder Treatment Market: Drivers and Restraints

The global psychotic disorder treatment market is anticipated to register a significant CAGR over a forecast period. The increasing research and development activities for the new drugs and new combinations of drugs to minimize the adverse effects  of the antipsychotics drugs and increase safety and efficacy of the drug is anticipated to boost the demand for the psychotic disorder drugs and drives the global psychotic disorder treatment market. Increasing the number of prevalence of severe psychotic disorder is likely to fuel the growth of global psychotic disorder treatment market. The rising in the awareness among people is also anticipated to drives the global psychotic disorder treatment market.

However, the possible side effects of the antipsychotics drugs may hamper the demand for the psychotic disorder treatment and restrain the growth of the global psychotic disorder treatment market. Lack of specific drugs and methods is a significant challenge to ensure the treatment is another factor that hinder the demand for the psychotic disorder treatment and restrain the growth of global psychotic disorder treatment market.

Psychotic Disorder Treatment Market: Segmentation

The global Psychotic disorder treatment market is segmented on the basis of drug type, indication and distribution channel:

On the basis of drug type, the global psychotic disorder treatment market is segmented into:
Atypical antipsychotics
Phenothiazine antipsychotics
Thioxanthenes
Miscellaneous antipsychotics agents
On the basis of indication, the global psychotic disorder treatment market is segmented into:
Schizophrenia
Bipolar disorder
Delusional disorder
Drug induced psychosis
Organic psychosis
On the basis of distribution channel, the global psychotic disorder treatment market is segmented into:
Hospital pharmacies
Retail pharmacies
Drug store
E-commerce
Psychotic Disorder Treatment Market: Regional Outlook

On the basis of regional presence, the global psychotic disorder treatment market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan, and Middle East & Africa. Currently, North America is contributing the leading shares to the global psychotic disorder treatment market in terms of value due to increase in the number of prevalence of severe psychotic disorder among people and is anticipated to register a significant CAGR over a forecast period. APEJ is also contributing moderate shares to the market and is expected to show a robust growth to the global psychotic disorder treatment market. Europe is also most lucrative market for the psychotic disorder treatment market. MEA is at a nascent stage to the global psychotic disorder treatment market and anticipated to register a decent growth to the market over a forecast period. Overall, the global psychotic disorder treatment market is expected to show significant growth over a forecast period.

Request Report TOC: https://www.factmr.com/connectus/sample?flag=T&rep_id=568
Psychotic Disorder Treatment Market: Key Players

Some of the major market players in psychotic disorder treatment market globally includes: Teva Pharmaceutical Industries Ltd, Sanofi S.A., Allergan, Plc, Pfizer Inc, Novartis International AG, Merck & Co., Inc., Johnson & Johnson Services, Inc., Amgen Inc., F. Hoffmann-La Roche Ltd, Mylan N.V. and others. These companies are highly focused on the development of advanced Psychotic disorder treatment devices further contributing to the growth of psychotic disorder treatment globally.

Reports Details @ https://www.factmr.com/report/568/psychotic-disorder-treatment-market

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Follow us in Linkedin: https://www.linkedin.com/company/factmr/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Psychotic Disorder Treatment Market to Witness Widespread Expansion During 2017 to 2027 here

News-ID: 1130471 • Views: 115

More Releases from Fact.MR

Global Truck Cranes Market Forecast, Trend Analysis & Competition Tracking durin …
According to Fact.MR, the truck cranes market is foreseen to register volume sales of over 9,300 Units in 2018, up by370 units in 2017. Overall growth of the market can be attributed to, Increasing investments in infrastructure-oriented development Buoyancy in utilities and power distribution sectors where truck cranes find significant application OEMs’ efforts to expand truck crane product portfolio with enhanced operational efficiency While demand for construction and heavy-duty equipment remains perennial, Fact.MR says
North America Accounts for Over 30% of Overall Aluminum Powder Sales, finds Fact …
According to a recently published Fact. MR report, global sales of aluminum powder in 2018 exceeded 110 Thousand tons and is expected to grow at moderate rate in the forecast period. According to the study, North America will maintain its supremacy in the market for aluminum powder, owing to the widespread demand from the region's automotive and aerospace sectors. The rising demand of lightweight materials in the automotive and aerospace
“Petroleum-Based to Bio-Based Propylene Glycol” is a Key Trend, Finds Fact.M …
The recently published research report by Fact.MR regarding the global propylene glycol market includes product classification and current synopsis along with product upgrades and innovations. The propylene glycol market was pegged at more than 2,500 Thousand Tons in 2018, and the global market is likely to witness a strong growth rate during the forecast period on the backdrop of increasing building & construction activities along with expanding production capacities of
Isocyanates Manufacturers Leveraging Advancements and Modernization in the Adhes …
The recently published report by Fact.MR regarding the global isocyanates market includes product classification and current synopsis along with product upgrades and innovations. Increasing demand from the building and automotive industries is increasing the polyurethane consumption in numerous consumer and industrial applications. Moreover, the thriving pharmaceutical industries, and isocyanates advantageous characteristics are the primary drivers for development in the worldwide isocyanate market. Burgeoning isocyanate acceptance for use in newer vertical

All 5 Releases


More Releases for Psychotic

Psychotic Disorder Treatment Market Value Share, Supply Demand, share and Value …
Psychotic Disorder Treatment Market: Snapshot Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable
08-31-2018 | Health & Medicine
Fact.MR
Psychotic Disorder Treatment Market Scenario with Demand, Production, Growth Fac …
A fresh study, covering “Psychotic Disorder Treatment Market Forecast, Trend Analysis & Competition Tracking - Global Review 2017 to 2027” has been broadcasted to wide online repository of FactMR, which presents deep focus on the Psychotic Disorder Treatment Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends
Psychotic Disorder Treatment Market Competitive Analysis 2017-2027
Psychotic Disorder Treatment Market: Snapshot Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable
One of the most popular ADHD drugs may cause hallucinations and other psychotic …
In the scientific article recently published in Scandinavian Journal of Child and Adolescent Psychiatry and Psychology, Erica Ramstad and others reviewed the existing evidence between various psychotic symptoms such as hallucinations, problems with concentration or anxiety with methylphenidate, a drug commonly prescribed as a treatment for attention deficit hyperactivity disorder (ADHD) and narcolepsy. Methylphenidate is a stimulant that increases the activity of the central nervous system, helps to combat fatigue, improves
Psychotic Disorder Treatment Market Report Explored in Latest Research
Psychotic Disorder Treatment Market: Snapshot Treatment strategies for managing patients with psychotic disorders are multi-faceted. Over the past couple of decades, doctors have been exploring the effectiveness of various therapies for psychotic disorders, particularly for schizophrenia. While strategies on medications have had substantial impacts on treating the symptoms in patients, there lurks significant risk of relapse, especially in case of acute psychotic episodes. In recent times, this has been driving considerable
Anti-Psychotic Drugs Market - Global Industry Analysis 2025
Anti-psychotic drugs, also called tranquilizers or neuroleptics, are a specific type of medication that are majorly used for the treatment of schizophrenia or bipolar disorder. They are used to manage psychosis, including hallucinations, delusions, and disordered thought of paranoia, among others. Anti-psychotic drugs are effective for the treatment of psychosis in a short duration. These drugs block the dopamine receptors in the dopaminergic pathways of the brain, thereby repressing the